Organon & Co. (OGN)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

7 annual periodsNewest to oldest
2025202420232022202120202019
Revenue$6.22B$6.40B$6.26B$6.17B$6.30B$6.53B$7.78B
Gross profit$3.31B$3.71B$3.75B$3.88B
Research & development$366.0M$469.0M$528.0M$471.0M$339.0M$210.0M$220.0M
Net income$187.0M$864.0M$1.02B$917.0M$1.35B$2.16B$3.22B
Basic EPSper diluted share$0.72$3.36$4.01$3.61$5.33$8.52$12.69
Diluted EPSper diluted share$0.72$3.33$3.99$3.59$5.31$8.52$12.69

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys8$1.51M disclosed value
Sells (SEC code S)1$353.1K disclosed value
9 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
May 6, 2026Form 4/AHolzbaur LynetteSVP and Corporate ControllerSellCommon Stock26.4K$13.35$353.1K0
May 6, 2026Form 4Holzbaur LynetteSVP and Corporate ControllerBuyCommon Stock26.4K$13.35$353.1K52.9K
Nov 12, 2025Form 4COX CARRIE SMITHExecutive ChairBuyCommon Stock · indirect65.4K$7.67$501.6K77.9K
May 14, 2025Form 4COX CARRIE SMITHDirectorBuyCommon Stock12.5K$8.07$100.6K12.5K
May 7, 2025Form 4Falcione AaronChief Human Resources OfficerBuyCommon Stock5.5K$8.77$48.2K63.0K